These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3902764)

  • 1. Structure activity relationships of spiramycins.
    Omura S; Sano H; Sunazuka T
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of spiramycins. IV. Synthesis and in vitro and in vivo activities of 3'',4''-diacylates and 3,3'',4''-triacylates of spriamycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):760-72. PubMed ID: 6469870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of spiramycins. I. Synthesis of the acetal derivatives of neospiramycin I.
    Sano H; Inoue M; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1983 Oct; 36(10):1336-44. PubMed ID: 6643282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of spiramycins. V. Synthesis and antibacterial activity of 3'- or 4''-de-N-methylspiramycin I and their N-substituted derivatives.
    Sano H; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Feb; 38(2):186-96. PubMed ID: 3997666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits.
    Siegrist S; Lagouardat J; Moreau N; LeGoffic F
    Eur J Biochem; 1981 Apr; 115(2):323-7. PubMed ID: 6786880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
    Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to ribosomes and inhibitory effect on protein synthesis of the spiramycin antibiotics.
    Vazquez D
    Life Sci; 1967 Apr; 6(8):845-53. PubMed ID: 4962201
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationships of O-acyl derivatives of leucomycin for antimicrobial and ribosome-binding activities.
    Tanaka H; Moriguchi I; Hirono S; Omura S
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2803-8. PubMed ID: 4085039
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pharmacokinetic studies on spiramycin and acetylspiramycin in rats].
    Inoue A; Deguchi T
    Jpn J Antibiot; 1982 Aug; 35(8):1998-2004. PubMed ID: 7154248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spiramycin resistance in Staphylococcus aureus. The stoichiometry of spiramycin-binding to ribosomes from spiramycin-sensitive, intermediate- and high-resistant strains.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):177-8. PubMed ID: 5309854
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis, antimicrobial evaluation and structure-activity relationships within 23-modified derivatives of 5-O-mycaminosyltylonolide.
    Kirst HA; Toth JE; Wind JA; Debono M; Willard KE; Molloy RM; Paschal JW; Ott JL; Felty-Duckworth AM; Counter FT
    J Antibiot (Tokyo); 1987 Jun; 40(6):823-42. PubMed ID: 3610835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.